Cannassure Therapeutics (Israel) Buy Hold or Sell Recommendation

CSURE Stock   1,120  103.00  10.13%   
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Cannassure Therapeutics is 'Cautious Hold'. Macroaxis provides Cannassure Therapeutics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding CSURE positions. The advice algorithm takes into account all of Cannassure Therapeutics' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Cannassure Therapeutics' buy or sell advice are summarized below:
Real Value
850.75
Hype Value
1.1 K
Market Value
1.1 K
Naive Value
1.3 K
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Cannassure Therapeutics given historical horizon and risk tolerance towards Cannassure Therapeutics. When Macroaxis issues a 'buy' or 'sell' recommendation for Cannassure Therapeutics, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Cannassure Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
In addition, we conduct extensive research on individual companies such as Cannassure and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Cannassure Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.

Execute Cannassure Therapeutics Buy or Sell Advice

The Cannassure recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Cannassure Therapeutics. Macroaxis does not own or have any residual interests in Cannassure Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Cannassure Therapeutics' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Cannassure TherapeuticsBuy Cannassure Therapeutics
Cautious Hold

Market Performance

GoodDetails

Volatility

Out of controlDetails

Hype Condition

StaleDetails

Current Valuation

OvervaluedDetails

Odds Of Distress

Below AverageDetails

Economic Sensitivity

Hyperactively responds to market trendsDetails

Analyst Consensus

Not AvailableDetails

Reporting Quality (M-Score)

InapplicableDetails
For the selected time horizon Cannassure Therapeutics has a Mean Deviation of 30.51, Semi Deviation of 7.72, Standard Deviation of 113.28, Variance of 12832.76, Downside Variance of 159.24 and Semi Variance of 59.61
Macroaxis provides advice on Cannassure Therapeutics to complement and cross-verify current analyst consensus on Cannassure Therapeutics. Our investment recommendation engine determines the company's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon. To make sure Cannassure Therapeutics is not overpriced, please confirm all Cannassure Therapeutics fundamentals, including its shares outstanding, gross profit, as well as the relationship between the Gross Profit and earnings per share .

Cannassure Therapeutics Trading Alerts and Improvement Suggestions

Cannassure Therapeutics is way too risky over 90 days horizon
Cannassure Therapeutics appears to be risky and price may revert if volatility continues
The company reported the revenue of 16.32 M. Net Loss for the year was (28.54 M) with loss before overhead, payroll, taxes, and interest of (14.17 M).
Cannassure Therapeutics generates negative cash flow from operations
About 51.0% of the company shares are held by company insiders

Cannassure Therapeutics Returns Distribution Density

The distribution of Cannassure Therapeutics' historical returns is an attempt to chart the uncertainty of Cannassure Therapeutics' future price movements. The chart of the probability distribution of Cannassure Therapeutics daily returns describes the distribution of returns around its average expected value. We use Cannassure Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Cannassure Therapeutics returns is essential to provide solid investment advice for Cannassure Therapeutics.
Mean Return
16.82
Value At Risk
-17.65
Potential Upside
27.67
Standard Deviation
112,000
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Cannassure Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Cannassure Therapeutics Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Cannassure Therapeutics or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Cannassure Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Cannassure stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over NYSE Composite
16.22
β
Beta against NYSE Composite4.80
σ
Overall volatility
129.68
Ir
Information ratio 0.15

Cannassure Therapeutics Volatility Alert

Cannassure Therapeutics is showing large volatility of returns over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Cannassure Therapeutics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Cannassure Therapeutics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

Cannassure Therapeutics Fundamentals Vs Peers

Comparing Cannassure Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Cannassure Therapeutics' direct or indirect competition across all of the common fundamentals between Cannassure Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Cannassure Therapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Cannassure Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Cannassure Therapeutics by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Cannassure Therapeutics to competition
FundamentalsCannassure TherapeuticsPeer Average
Return On Equity-2.11-0.31
Return On Asset-0.52-0.14
Profit Margin(1.53) %(1.27) %
Operating Margin(1.52) %(5.51) %
Current Valuation56.54 M16.62 B
Shares Outstanding51.17 M571.82 M
Shares Owned By Insiders51.49 %10.09 %
Shares Owned By Institutions1.00 %39.21 %
Price To Sales0.05 X11.42 X
Revenue16.32 M9.43 B
Gross Profit(14.17 M)27.38 B
EBITDA(20.64 M)3.9 B
Net Income(28.54 M)570.98 M
Book Value Per Share0.14 X1.93 K
Cash Flow From Operations(20.82 M)971.22 M
Earnings Per Share(0.31) X3.12 X
Number Of Employees4418.84 K
Beta0.69-0.15
Market Capitalization384.26 K19.03 B

Cannassure Therapeutics Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Cannassure . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Cannassure Therapeutics Buy or Sell Advice

When is the right time to buy or sell Cannassure Therapeutics? Buying financial instruments such as Cannassure Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Cannassure Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Non-Metallic and Industrial Metal Mining Thematic Idea Now

Non-Metallic and Industrial Metal Mining
Non-Metallic and Industrial Metal Mining Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Non-Metallic and Industrial Metal Mining theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Non-Metallic and Industrial Metal Mining Theme or any other thematic opportunities.
View All  Next Launch
Check out Cannassure Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
Note that the Cannassure Therapeutics information on this page should be used as a complementary analysis to other Cannassure Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Complementary Tools for Cannassure Stock analysis

When running Cannassure Therapeutics' price analysis, check to measure Cannassure Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cannassure Therapeutics is operating at the current time. Most of Cannassure Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cannassure Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cannassure Therapeutics' price. Additionally, you may evaluate how the addition of Cannassure Therapeutics to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Transaction History
View history of all your transactions and understand their impact on performance
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Please note, there is a significant difference between Cannassure Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cannassure Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cannassure Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.